SLDX (Stella Diagnostics) Total Long-Term Assets : $0.44 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Stella Diagnostics's Total Long-Term Assets for the quarter that ended in Sep. 2023 was $0.44 Mil.

Stella Diagnostics Total Long-Term Assets Historical Data

The historical data trend for Stella Diagnostics's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Total Long-Term Assets Chart

Stella Diagnostics Annual Data

Trend

Total Long-Term Assets

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Total Long-Term Assets	-	0.44

Stella Diagnostics Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Stella Diagnostics Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.